Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MK-677 for Women 45-55 Perimenopause: Protocol Comparison

Standard Daily (25mg) 25mg once daily, 60–90 minutes before bed Sleep improvement: 1–2 weeks. Lean mass/fat changes: 12–16 weeks Maximal IGF-1 elevation, consistent anabolic signaling Water retention peaks weeks 2–6, then stabilizes Split Dose (12.5mg BID) 12.

This comparison does not assign a generated winner or score.

  • Standard Daily (25mg)
  • 25mg once daily, 60–90 minutes before bed
  • Sleep improvement: 1–2 weeks. Lean mass/fat changes: 12–16 weeks
  • Maximal IGF-1 elevation, consistent anabolic signaling
  • Water retention peaks weeks 2–6, then stabilizes
  • Split Dose (12.5mg BID)
  • 12.5mg morning + 12.5mg pre-bed
  • Reduced appetite surge, steadier GH elevation
  • Requires consistent timing; slightly lower peak IGF-1
  • Cycling (5 days on, 2 off)
  • 25mg daily for 5 days, 2-day break each week
  • Sleep improvement: 1–2 weeks. Lean mass/fat changes: 14–18 weeks (slower)
  • May reduce water retention, lower cost
  • Less consistent IGF-1 levels; benefits accrue more slowly
  • Pre-Bed Only (20mg)
  • 20mg 60 minutes before sleep
  • Sleep improvement: 1–2 weeks. Lean mass/fat changes: 16+ weeks
  • Optimized for sleep quality over body composition
  • Lower total IGF-1 exposure; lean mass gains less pronounced
  • Professional Assessment
  • Daily dosing at 25mg produces the most reliable increases in IGF-1 and the fastest improvements in body composition and bone turnover markers. Split dosing reduces appetite side effects but requires stricter adherence. Cycling protocols are popular among users concerned about long-term receptor sensitivity, though clinical evidence for desensitization at 25mg daily is minimal. Pre-bed-only protocols prioritize sleep enhancement and are appropriate for women whose primary goal is improved rest rather than lean mass preservation.
More references

Related material